baber/WOPTO huggingface dataset:
Patent AU-2003219479-A1 (AU)
Title: Currency verification
Inventor: SLEPYAN EDWARD
IPC: G07D7/12
Filed: 2003-03-10
Abstract: A method for verifying authenticity of a certificate under test, wherein an authentic version of the certificate has a known watermark in a predetermined watermark region thereof. The method includes capturing an image of at least a portion of the watermark region of the certificate under test. A correlation is found between the image of the watermark region and the known watermark. Responsive to the correlation, a portion of the image of the watermark region is registered with the known watermark, and a range of intensity values in the registered portion of the image is measured. A vector is defined in a decision space, the vector having coordinates given by the range of the intensity values and by a value of the correlation between the image of the watermark region and the known watermark. The certificate under test is determined to be authentic if the vector falls within a predefined area of the decision space.
Patent AU-2003227030-A1 (AU)
Title: Process for exchanging the anions of cationic compounds
Inventor: MOCKLI PETER
IPC: D06P3/04
Filed: 2003-03-04
Abstract: Process for converting sparingly soluble salts of cationic organic compounds and inorganic acids into more readily soluble salts of organic acids, which process comprises: a) preparing a sparingly water-soluble salt of the cationic organic compound with the anion of an inorganic acid, b) adding thereto, in a monohydric aliphatic alcohol, an alkali metal salt or an organic acid, c) filtering off the resulting sparingly soluble alkali metal salt of the inorganic acid, and d) optionally converting the resulting solution into a solid form.
Patent AU-2003239383-A1 (AU)
Title: Vitamin-targeted imaging agents
Inventor: LEAMON CHRISTOPHER PAUL
IPC: A61K47/48
Filed: 2003-05-06
Abstract: The invention provides a use of a compound of the formula  Lyophilisates and formulates with the compound at also provided.
Patent AU-2003276270-A1 (AU)
Title: Rapid cooling method and device
Inventor: HAUSMANN GEORG
IPC: F25B21/02
Filed: 2003-11-06
Abstract: Disclosed is a rapid cooling device for freezing food, comprising a container (11) which is filled with a heat transfer liquid and is provided with at least one flexible wall (15). Said container (11) is part of a circuit which also comprises a tank (8) for the heat transfer liquid.
Patent AU-2003280523-A1 (AU)
Title: Prevention, therapy and prognosis/monitoring in sepsis and septic shock
Inventor: HAVEKES ALOYSIUS MARIA
IPC: A61K38/00
Filed: 2003-06-27
Abstract: The invention relates to the use of a peptide which binds to lipopolysaccharide (LPS) or lipoteichoic acid (LTA), for manufacturing a pharmaceutical composition for treating sepsis or septic shock, wherein the peptide comprises the amino acid sequence of apolipoprotein CI (apoCI) or a part thereof that comprises at least the amino acids of the C-terminal helix of apoCI. The use of human apoCI is preferred. The peptide can be administered clinically to patients who have sepsis or threaten to develop sepsis. Measurement of the apoCI content in blood can be utilized for determining the severity and prognosis of the course of the septic condition or for monitoring an anti-sepsis treatment.
Patent AU-2003286115-A1 (AU)
Title: Printing presses comprising at least one printing cylinder
Inventor: BARROIS CLAUS-DIETER
IPC: B41F7/08
Filed: 2003-11-03
Abstract: The printing machine has at least one printing cylinder (06,07) and a relatively displaced inking mechanism (11,12) and printing cylinder changing device, which are coupled together for movement to or from the printing cylinder by a common displacement drive, e.g. a linear motor. The printing cylinder is supported in a stationary part (02) of the printing machine and the inking mechanism and the printing cylinder changing device are supported by a movable part (08,09) of the printing machine.
Patent AU-2003296691-A1 (AU)
Title: Control of the configuration status of a mobile radio device for a multicast service
Inventor: KROTH NORBERT
IPC: H04W4/06
Filed: 2003-12-19
Abstract: A configuration status (CS) to be assumed by a subscriber station after receiving a piece of multicast useful data (MULTICAST INFO) is adjusted. The multicast data is available via radio waves as a service to a group of subscriber stations, of which one or more has access to first (IDLE) or second (CONNECTED) CS.  An Independent claim is also included for a device for radio access control between a base station and subscriber stations over an aerial interface in a radiotelephone communications system for carrying out the method of the present invention.
Patent AU-2003297873-A1 (AU)
Title: Derivation of eigenvectors for spatial processing in mimo communication systems
Inventor: WALLACE MARK S
IPC: H04L25/02
Filed: 2003-12-09
Abstract: Techniques for deriving eigenvectors based on steered reference and used for spatial processing. A steered reference is a pilot transmission on one eigenmode of a MIMO channel per symbol period using a steering vector for that eigenmode. The steered reference is used to estimate both a matrix Sigma of singular values and a matrix U of left eigenvectors of a channel response matrix H . A matrix U with orthogonalized columns may be derived based on the estimates of Sigma and U, e.g., using QR factorization, minimum square error computation, or polar decomposition. The estimates of Sigma and U (or the estimate of Sigma and the matrix U) may be used for matched filtering of data transmission received via a first link. The estimate U of or the matrix U may also be used for spatial processing of data transmission on a second link (for reciprocal first and second links).
Patent AU-2003302082-A1 (AU)
Title: Electrosurgical generator and method for detecting malfunction
Inventor: THOMPSON RICHARD
IPC: A61B18/12
Filed: 2003-10-27
Abstract: Output power delivery from an electrosurgical generator is evaluated to avoid malfunctions and risk conditions. Output power is delivered in a selected delivery path and the flow of output power is sensed in the selected delivery path and other delivery paths which have not been selected. The output power delivery is terminated upon determining that output power is not flowing in the selected delivery path or that output power is flowing in a delivery path that was not selected.
Patent AU-2004200389-A1 (AU)
Title: Measurement Device for Determining Oxygen Activity in Molten Metal or Slag
Inventor: HABETS DANNY
IPC: G01N27/411
Filed: 2004-01-29
Abstract: The small solid electrolyte tube (5) has a coating on its outer surface. This is a mixture of calcium zirconate and a fluoride. The coating is 10-100 mu m thick, and only partly covers the outer surface of the solid electrolyte tube. The corresponding coated tube is claimed separately.
Patent AU-2004200461-A1 (AU)
Title: Issuing a publisher use license off-line in a digital rights management (DRM) system
Inventor: BOURNE STEVE
IPC: H04L29/06
Filed: 2004-02-10
Abstract: A publishing user publishes digital content and issues to itself a corresponding digital publisher license to allow itself to render the published digital content. The publishing user is supplied with a publishing certificate from a digital rights management (DRM) server, where the publishing certificate allows the publishing user to so publish the digital content and to so issue the publisher license. <IMAGE>
Patent AU-2004229159-A1 (AU)
Title: Medical active agent patch optically less visible on skin
Inventor: BRACHT STEFAN
IPC: A61K9/70
Filed: 2004-04-08
Abstract: A transparent or translucent medical active substance patch is provided that includes a matrix of monolayer or multilayer configuration with at least one active substance-containing layer contained therein and a backing layer connected with the matrix. The patch, having been applied to the skin of a first person, has a lightness color value L1 at a place of the skin covered by the patch which is not less than 50% and not more than 200% of a lightness color value L2, with L2 being the lightness value of the region of skin of the same person which surrounds the applied patch, with the same being true of the skin of a second or any other person, provided that for all the persons mentioned, the L2 of their respective skin is in the range from 5° to 100°, especially in the range from 20° to 90°.
Patent AU-2004282827-A1 (AU)
Title: Method and apparatus for reprogramming a programmed controller of a power driven wheelchair
Inventor: WAKEFIELD THEODORE D II
IPC: G05B19/042
Filed: 2004-09-16
Abstract: Apparatus for reprogramming a programmed controller of a power driven wheelchair comprises: a reprogrammable, non-volatile memory programmed with a plurality of programs executable by the controller to operate the wheelchair, the non-volatile memory disposed at the wheelchair and coupled to the wheelchair controller; a general-purpose computer programmed to reprogram the non-volatile memory while disposed at the wheelchair, the programmed computer for storing main programs for use in reprogramming the non-volatile memory, the programmed computer being coupleable to the wheelchair controller for accommodating an exchange of data therebetween; and wherein the wheelchair controller being operative to communicate with the programmed computer to reprogram the non-volatile memory with the main programs while the non-volatile memory is disposed at the wheelchair. Methods for reprogramming the non-volatile memory are also disclosed.
Patent WO-2005103025-A1 (WO)
Title: Procede de synthese d'isoflavene et catalyseur
Inventor: HEATON ANDREW
IPC: B01J37/06
Filed: 2005-04-21
Abstract: L'invention concerne un procédé amélioré de synthèse de composés d'isoflavan-4-ol et d'isoflavène hydroxy substitués à partir d'isoflavones. L'invention concerne également un nouveau catalyseur d'hydrogénation incorporant une base et ses utilisations.
Patent AU-2005202097-A1 (AU)
Title: Retractable counterweight for straight-boom aerial work platform
Inventor: BACKER ROBERT D
IPC: B66F9/06
Filed: 2005-05-16
Abstract: An aerial work platform apparatus includes a shiftable counterweight (36) which shifts in response to movement of the boom (32) in order to maintain optimum balance of the apparatus during movement of the boom and platform (22). The counterweight shifts towards and away from the front of the apparatus, and also in a vertical direction. The counterweight is supported by rollers (40) and moves along an inclined track (42). The counterweight is pushed by a link (46) mounted on the second (32') end of the boom, or in an alternative embodiment by a hydraulic cylinder (58), which is linked to the boom lift cylinder (54) in a master-slave arrangement.  <IMAGE>
Patent AU-2005214101-A1 (AU)
Title: Method for preventing defective ageing of white wines
Inventor: ORTIZ-JULIEN ANNE
IPC: C12G1/02
Filed: 2005-01-19
Abstract: The procedure consists of adding glutathione-enriched yeast to white wine must at the beginning, during or at the end of the alcoholic fermentation stage. The glutathione content of the yeast is over 0.5 per cent and preferably 1.5 per cent by weight of the dry material, and is added to the wine must at a rate of 0.1 - 1.0 g/l, and preferably 0.5 g/l, giving at least 5 mg and preferably about 9 mg of glutathione per litre of must. The glutathione-enriched yeast can be in the form of active or inactivated dry yeast, and can be used as part of the yeast inoculated in the must to start the alcoholic fermentation.
Patent AU-2005220241-A1 (AU)
Title: Reduction of porcine circovirus-2 viral load
Inventor: HARDING JOHN
IPC: C12Q1/68
Filed: 2005-10-07
Abstract: Porcine circovirus-2 (PCV-2) is a recently identified agent wherein the potential spectrum of PCV-2-associated disease has been expanded by evidence of vertical and sexual transmission and associated reproductive failure in swine populations. PCV-2 was isolated from a litter of aborted piglets from a farm experiencing late term abortions and stillbirths. Severe, diffuse myocarditis was present in one piglet associated with extensive immunohistochemical staining for PCV-2 antigen. Variable amounts of PCV-2 antigen were also present in liver, lung and kidney of multiple fetuses. Inoculation of female pigs with a composition including an immunogen from PCV-2 or an epitope of interest from such an immunogen or with a vector expressing such an immunogen or epitope of interest prior to breeding, such as within the first five weeks of life, or prior to the perinatal period, or repeatedly over a lifetime, or during pregnancy, such as between the 6th and 8th and/or the 10th and 13th weeks of gestation, can prevent myocarditis, abortion and intrauterine infection associated with porcine circovirus-2. In addition, innoculation of male and/or female pigs with the aforementioned compositions can be carried out to prevent transmission of PCV-2 from male to female (or vice versa) during mating. Thus, the invention involves methods and compositions for preventing myocarditis, abortion and intrauterine infection associated with porcine circovirus-2.
Patent AU-2005229505-A1 (AU)
Title: 4- (sulfanyl-pyrimidin-4-ylmethyl) -morpholine derivatives and related compounds as GABA receptor ligands for the treatment of anxiety, depression and epilepsy
Inventor: SPOOREN WILL
IPC: C07D239/42
Filed: 2005-02-22
Abstract: The present invention relates to compounds of formula wherein X is -S- or -NH-; R<SUP>3</SUP>/R<SUP>4 </SUP>together with the N-atom to which they are attached form a non aromatic 5, 6 or 7 membered ring, which optionally contains in addition to the N-atom one additional heteroatom selected from the group consisting of O, S and N, and wherein the ring is optionally substituted by hydroxy, lower alkyl, lower alkoxy, -NR<SUB>2</SUB>, -CONR<SUB>2</SUB>, -CO-lower alkyl or benzyl; or R<SUP>3</SUP>/R<SUP>4 </SUP>form together with the N-atom to which they are attached a heterocyclic ring system, containing two or three rings and which optionally contains one or two additional heteroatoms selected from the group consisting of N and O and which has no more than 20 carbon atoms; and R, R<SUP>1</SUP>, R<SUP>2</SUP>, and R<SUP>5 </SUP>are as defined herein and to pharmaceutically suitable acid addition salts thereof. It has been found that the compounds of the invention are active on the GABA<SUB>B </SUB>receptor and therefore are useful for the treatment of anxiety, depression, epilepsy, schizophrenia, cognitive disorders, spasticity and skeletal muscle rigidity, spinal cord injury, multiple sclerosis, amyotrophic lateral sclerosis, cerebral palsy, neuropathic pain and craving associated with cocaine and nicotine, psychosis, panic disorder, posttraumatic stress disorders and gastro-intestinal disorders.
Patent AU-2005241625-A1 (AU)
Title: Method of and system for storage of I-WLAN temporary identities
Inventor: VERON CHRISTIAN HERRERO
IPC: H04W12/06
Filed: 2005-05-04
Abstract: A temporary-identity-storage method for user equipment includes receiving authentication challenge information and at least one temporary identity, processing the authentication challenge information, and determining whether the processing step results in successful authentication. The user equipment includes mobile equipment and a subscriber identity module. Responsive to a determination that the authentication was successful, the received at least one temporary identity is considered to be valid. If the received at least one temporary identity is at least one pseudonym and an appropriate data file to store the at least one pseudonym is available in the subscriber identity module, the at least one pseudonym is stored and any previously-stored pseudonym is over-written in the subscriber identity module. If the received at least one temporary identity is at least one pseudonym and an appropriate data file to the store the at least one pseudonym is not available in the subscriber identity module, the at least one pseudonym is stored and any previously-stored pseudonym is over-written in the mobile equipment. This Abstract is provided to comply with rules requiring an Abstract that allows a searcher or other reader to quickly ascertain subject matter of the technical disclosure. This Abstract is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the claims. 37 CFR 1.72(b).
Patent AU-2005257667-A1 (AU)
Title: Process for complete utilisation of olivine constituents
Inventor: JORGENSEN TOM RAMES
IPC: C22B26/22
Filed: 2005-06-06
Abstract: A novel process for complete utilization of olivine is based on purification of brine by oxidation and precipitation of iron and nickel compounds.
Patent AU-2005268968-A1 (AU)
Title: Control of power breakers
Inventor: BOCKLE REINHARD
IPC: H02M3/155
Filed: 2005-07-25
Abstract: Desired performance of the switch (1), e.g. an FET, is specified in terms of the current and/or voltage profile at least during part of the switching operation. Actual performance during switching is measured (4, 5) and fed back (3) in terms of these variables. Switching control (9) is adjusted such that actual performance corresponds with desired performance : An independent claim is included for a corresponding computer software product.
Patent WO-2007059565-A1 (WO)
Title: Moteur a pistons libres a quatre temps
Inventor: CHEESEMAN PETER CHARLES
IPC: F01B1/00
Filed: 2006-11-21
Abstract: L’invention concerne un moteur à combustion interne à pistons libres à quatre temps. Le moteur (210) comprend une structure bloc-moteur (212) et une navette rigide (214) montée sur la structure bloc-moteur (212) de façon à effectuer un mouvement de va-et-vient par rapport à celle-ci le long d’un axe de navette linéaire (215). Le moteur (210) comprend en outre un réseau de passages d’admission (216) susceptibles d’être obturés hermétiquement de façon sélective, et un réseau de passages d’échappement (218) susceptibles d’être obturés hermétiquement de façon sélective. La navette (214) comprend une première partie de navette généralement cylindrique (220), une deuxième partie de navette généralement cylindrique (222) espacée axialement de la première partie de navette (220) et un châssis de navette (224) fixant rigidement la première partie de navette (220) par rapport à la deuxième partie de navette (222). Les première et deuxième parties de navette (220, 222) sont alignées axialement sur l’axe de navette (215). La première partie de navette (220) forme des première et deuxième surfaces de navette opposées (228, 232) et la deuxième partie de navette (222) forme des troisième et quatrième surfaces de navette opposées (236, 240). L’axe de navette (215) s’étend au centre des quatre surfaces de navette (228, 232, 236, 240). Le moteur (210) comprend en outre une première chambre (250) formée entre la première surface de navette (220) et la structure bloc-moteur (212), une deuxième chambre (252) formée entre la deuxième surface de navette (232) et la structure bloc-moteur (212), une troisième chambre (254) formée entre la troisième surface de navette (236) et la structure bloc-moteur (212), et une quatrième chambre (256) formée entre la quatrième surface de navette (240) et la structure bloc-moteur (212). Le châssis de navette (224) est situé à l’extérieur de chacune des chambres (250, 252, 254, 256).
Patent AU-2006202344-A1 (AU)
Title: Method for the improvement of islet signaling in diabetes mellitus and for its prevention
Inventor: DEMUTH HANS-ULRICH
IPC: A61K31/40
Filed: 2006-06-01
Abstract: The present invention discloses a method for therapeutically treating mammals, including but not limited to humans, to increase the relative insulin producing performance of endogenous pancreatic ²-cells and to cause differentiation of pancreatic epithelial cells into insulin producing ²-cells. Oral administration of a DP IV inhibitor causes the active form of GLP-1 to be preserved longer under physiological conditions. The extended presence of GLP-1, in particular in the pancreatic tissue facilitates differentiation and regeneration of the ²-cells already present that are in need of repair. These repaired insulin producing cells can contribute to the correction and maintenance of normal physiological glycemic levels.
Patent AU-2006219733-A1 (AU)
Title: Cytokine modulators using cyclic glycerides of essential polyunsaturated fatty acids
Inventor: HARBIGE LAURENCE S
IPC: A61P25/00
Filed: 2006-03-02
Abstract: A method of treating a patient in need of therapy for a cytokine dysregulation comprising administering to that patient a therapeutically effective dose of a compound of general formula: (I) wherein R1 and R2 together form a group —(CH2)n—CR4R5—(CH2)m— wherein n and m are independently selected integers 0, 1 or 2 and R4 and R5 are independently selected from H, C1-18 alkyl, C1-18alkoxy, C1-18n hydroxyalkyl, C2-18 alkenyl and C6-18aryl or aralykyl and R3 is the a fatty acyl group of an essential polyunsaturated fatty acid.
Patent AU-2006232548-A1 (AU)
Title: Ratcheting fixation plate
Inventor: VACCARO ALEXANDER R
IPC: A61B17/80
Filed: 2006-04-03
Abstract: Devices and methods for spinal fixation employ at least first and second plates that are configured to allow progressive sliding advancement of the plate members toward one another and limit movement of the plate members away from one another after installation. A spring member associated with one bone plate may engage toothed section(s) on the other bone plate. The bone plates may each have arms that are spaced from one another and engaged by corresponding arms on the other bone plate. There may be more than two bone plates, with multiple restricted movement regions.
Patent AU-2006280110-A1 (AU)
Title: Sanding tool with rotatable handle
Inventor: KIRSCHHOFFER JON A
IPC: B24B1/00
Filed: 2006-08-07
Abstract: A hand-held, manually-operated sanding tool including a base member, a clamping mechanism, a handle and a mounting assembly. The clamping mechanism is adapted to secure a sheet-like abrasive material to the base member. The handle includes a neck and a grip. The mounting assembly rotatably mounts the handle to the base member such that the neck extends from a top surface thereof and the handle is rotatable relative to the base member about an axis defined by the neck.
Patent AU-2006281946-A1 (AU)
Title: Joint space-time optimum filter (JSTOF) using QR and eigenvalue decompositions
Inventor: KEMENCZY ZOLTAN
IPC: H04B7/02
Filed: 2006-08-14
Abstract: A filter for reducing co-channel interference within a communications receiver may include a multi-channel, space-time filter circuit that filters n signal parts that have been split from a communications signal by jointly estimating space-time filter weights and multi-channel impulse responses (CIRs) based upon QR and eigenvalue decompositions. The filter may further include a multi-channel, matched filter circuit that receives multi-channel signals from the multi-channel, space-time filter circuit and has a filter response that is provided by a channel impulse response estimation from the space-time filter circuit.
Patent AU-2006318226-A1 (AU)
Title: Use of PARP-1 inhibitors
Inventor: MANDOLA MICHAEL
IPC: A61K31/44
Filed: 2006-11-27
Abstract: A method for improving the cytotoxic effect of Ecteinascidin-743 (ET-743) or an analog thereof on a tumor cell population in a patient the method including administering to the patient, sequentially or simultaneously, a therapeutically effective combination of a composition including ET-743 and an amount of a composition including a PARP-1 inhibitor effective to increase the cytotoxic effect of ET-743 on the tumor cell population. Anti-tumor compositions containing a therapeutically effective amount of ET-743 and an amount of a PARP-1 inhibitor effective to increase the tumor cytotoxicity of the ET-743 are also presented.